Marc Swanson
Pain Medicine · Salem, VANPI 1255350831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 346 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Medtronic at 58.5% of the total.
Across 346 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- AbbVie$786
- Collegium Pharmaceutical, Inc.$676
- Amgen$176
- Johnson & Johnson$173
- Biodelivery Sciences International, Inc.$146
- plus $1K from 25 others
What the payments were for
- Food & beverage$7,528100%
- Education$180%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 129 | $4,413 |
| AbbVie(2 entities) | 63 | $786 |
| Collegium Pharmaceutical, Inc. | 63 | $676 |
| Amgen(2 entities) | 11 | $176 |
| Johnson & Johnson | 11 | $173 |
| Biodelivery Sciences International, Inc. | 9 | $146 |
| Teva Pharmaceuticals USA, Inc. | 7 | $141 |
| Lilly USA, LLC | 3 | $97 |
| Scilex Pharmaceuticals Inc. | 5 | $91 |
| Arbor Pharmaceuticals, Inc. | 5 | $88 |
| Fidia Pharma USA Inc. | 4 | $73 |
| Novartis | 2 | $68 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Biohaven Pharmaceuticals, Inc. | 3 | $62 |
| Eisai Inc. | 4 | $56 |
| Assertio Therapeutics, Inc. | 3 | $56 |
| MDD US Operations, LLC | 3 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $45 |
| Si-bone, Inc. | 2 | $40 |
| Bioventus LLC | 2 | $34 |
| Merz Pharmaceuticals, LLC | 1 | $28 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Abbott | 1 | $23 |
| Boston Scientific | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| GRT US Holding, Inc. | 1 | $19 |
| KCI USA, Inc. | 1 | $15 |
| Shionogi Inc | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$882
- SYNCHROMED$264
- Accurian$262
- VANTA ADAPTIVESTIM$240
- INTELLIS ADAPTIVESTIM$236
- OSTEOCOOL RF ABLATION$129
- AUTOFILL$108
- KYPHON EXPRESS II KYPHOPAK TRAY$101
How this compares
$7,546 in reported general payments places this provider in the 80th percentile of 150 pain medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 189 | $3,699 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 107 | $2,968 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 68 | $2,236 |
| Fentanyl | 19 | $2,077 |
| Morphine Sulfate ErMorphine Sulfate | 57 | $1,369 |
| Pregabalin | 39 | $1,081 |
| Gabapentin | 73 | $989 |
| Hydromorphone Hcl | 29 | $583 |
| Morphine Sulfate | 11 | $454 |
| Tramadol Hcl | 21 | $422 |
| Celecoxib | 11 | $401 |
| Tizanidine Hcl | 24 | $365 |
| Methadone Hcl | 13 | $291 |
| Promethazine Hcl | 17 | $259 |
| Lorazepam | 31 | $190 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Salem
- George BaylorSalem$24K
- Anthony DragovichSalem$15K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Steven GershonVirginia Beach$78K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.